Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Abstract Background Secondary osteoporosis may occur in patients with rheumatoid arthritis (RA), causing irreversible joint damage and disability. Bisphosphonates, the recently developed bone resorption inhibitors, have demonstrated significant therapeutic effects on senile and postmenopausal osteop...

Full description

Bibliographic Details
Main Authors: Jun Xie, Shaohua Li, Lianbo Xiao, Guilin Ouyang, Lin Zheng, Yubiao Gu, Chengxin Gao, Xiuwei Han
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Zoledronic acid
Inflammation
Osteoporosis
Rheumatoid arthritis
Online Access:https://doi.org/10.1186/s13018-019-1492-3

Internet

https://doi.org/10.1186/s13018-019-1492-3

Similar Items